SecBot SecBot

WGSWW

GeneDx Holdings Corp.
Nasdaq· Services-Health Services· Inc. DE· CIK 0001818331 Healthcare & Medical Devices
No price
Market cap
$5.9K
Nano cap
Short interest
18.3K
≈0.1% of shares · −64.1%
Days to cover
1.0
at average volume
New fund stakes
0
Q2 2026 13F · 0 exits
Filing reports
2
analyzed by SecBot
SecBot read BEARISH 2 reports · latest
Balance 1 bearish · 0 bullish · 1 neutral oldest → newest, height = score
Avg score ·High conf. 2/2
Strongest BEARISH GeneDx reported Q1 2026 revenue of $102.3M (17% YoY growth but below $112.5M consensus) and an adjusted net…
All reports →

Price

Daily candles with volume.

Signal stack

Where each data set points today.

  • InstitutionsMIXED

    Q2 2026: 1 added (0 new), 0 trimmed or exited.

  • Short sellersCOVERING

    Short interest −64.1% to 18.3K shares. 1.0 days to cover, ≈0.1% of shares.

Who's buying

13F· Q2 2026
0
new positions
0
exits
FundMoveSharesValue
Clear Street Group Inc.ADD199$1.00
WOLVERINE ASSET MANAGEMENT LLCADD59,948$2.8K
UBS Group AGDOUBLED2,344$110.00
UBS Group AGNEAR_EXIT377$41.00
UBS Group AGTRIM49,588$3.6K
WOLVERINE ASSET MANAGEMENT LLCTRIM29,386$6.2K
WOLVERINE ASSET MANAGEMENT LLCADD46,545$3.5K

Quarterly 13F filings are due 45 days after each quarter ends.

Earnings setup

Estimates
PeriodEPS est.Range30D rev.Revenue
Current QNoneNoneNo data$111.0M
Next QNoneNoneNo data$126.1M
Current FYNoneNoneNo data$478.4M
Next FY🔒 Fresh data, subscribers only
Catalysts
Scheduled dates and disclosed events: earnings, FDA and trial readouts, halts, press releases. Colored dot = impact.
Recent
Jul 22, 2026
Listing
Delisted: WGSWW, removed from the Nasdaq symbol directory
GeneDx Holdings Corp. - Warrant

Short side

FINRA· Jul 15, 2026
18,319
shares short
-64.1%
vs prior settlement
1.0
days to cover
≈0.1%
of shares outstanding
Recent activity
The latest filings, insider trades, analyst actions, press and options flow, newest first.
Jul 22, 2026 Listing status
Delisted: WGSWW, removed from the Nasdaq symbol directory
GeneDx Holdings Corp. - Warrant
Jun 30, 2026 Inst.
Clear Street Group Inc. · ADD
199 shares ($1.00)
May 4, 2026 SEC
GeneDx reported Q1 2026 revenue of $102.3M (17% YoY growth but below $112.5M consensus) and an adjusted net loss of…
8-K · Impact 8/10
Apr 29, 2026 SEC
Director Katherine Stueland filed a Form 144 to sell 16,415 shares of Class A Common Stock valued at approximately…
144 · Impact 2/10
Dec 31, 2025 Inst.
WOLVERINE ASSET MANAGEMENT LLC · ADD
59,948 shares ($2.8K)

SecBot reports

2 filings · 0 bullish · 1 bearish · 1 neutral
All WGSWW filing & press-release reports (2)